Although it is mechanistically conceivable that immunosuppressive therapy impairs the type I interferon immune response, previous studies demonstrated that MxA is a reliable marker for viral infections in immunocompromised children after allogenic stem cell transplantation or chemotherapy [23, 24]. This evidence concerns the gene MX1 and viral infectious disease.